All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @ripdaddy.20 on TikTok · 39s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @ripdaddy.20's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Hey guys, I am showing you all my face before ozimpic I was
  2. 0:06266 times this video as you can see my face is big is loaded my cheeks are big under my chin is fat
  3. 0:16My arms is just big
  4. 0:19Okay, but yeah, so that was my face before ozimpic
  5. 0:23Now this is my face with ozimpic. I am a month and a half into taking my ozimpic
  6. 0:30And my face has dropped tremendously. I am 225 pounds at the moment, but it has been wonderful

This TikTok about 'Ozempic face' misses the real story

FONITA ❤️

TikTok creator

81.3K viewsWatch on TikTok

Quick answer

The creator reports losing approximately 41 pounds over six weeks on semaglutide, describing marked facial volume reduction they attribute directly to the medication. While GLP-1 receptor agonists do produce documented facial fat loss during significant weight reduction, this rate of loss substantially exceeds the average observed in the STEP clinical trial program. Viewers should be aware that early weight loss on semaglutide often includes a large water-weight component and that individual results vary considerably based on dose, diet, and metabolic factors.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For This TikTok about 'Ozempic face' misses the real story, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "This TikTok about 'Ozempic face' misses the real story" from FONITA ❤️. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator reports losing approximately 41 pounds over six weeks on semaglutide, describing marked facial volume reduction they attribute directly to the medication.

The reason this review is not generic is the source wording and the canonical claim label "glp1 month 2 of ozempic face drop i m posting my accomplishments." In this clip, the useful excerpt is: "Hey guys, I am showing you all my face before ozimpic I was 266 times this video as you can see my face is big is loaded my cheeks are big under my chin is fat My arms is just big Okay, but yeah, so that was my face before ozimpic Now this..." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Facial fat loss from GLP-1 medications is real and documented, but it results from overall body weight reduction, not a targeted facial effect.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator reports losing approximately 41 pounds over six weeks on semaglutide, describing marked facial volume reduction they attribute directly to the medication.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator reports losing approximately 41 pounds over six weeks on semaglutide, describing marked facial volume reduction they attribute directly to the medication. While GLP-1 receptor agonists do produce documented facial fat loss during significant weight reduction, this rate of loss substantially exceeds the average observed in the STEP clinical trial program. Viewers should be aware that early weight loss on semaglutide often includes a large water-weight component and that individual results vary considerably based on dose, diet, and metabolic factors.
  • STEP 1 trial data (Wilding et al., 2021, NEJM) shows average semaglutide users lose about 14.9% of body weight over 68 weeks, not six weeks.
  • Facial fat loss from GLP-1 medications is real and documented, but it results from overall body weight reduction, not a targeted facial effect.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • STEP 1 trial data (Wilding et al., 2021, NEJM) shows average semaglutide users lose about 14.9% of body weight over 68 weeks, not six weeks.
  • Facial fat loss from GLP-1 medications is real and documented, but it results from overall body weight reduction, not a targeted facial effect.
  • Losing 41 pounds in six weeks would require an estimated deficit of roughly 2,400 calories per day, which raises questions about how much was water weight versus fat mass.
  • Up to 44% of semaglutide users in clinical trials experience nausea or vomiting (Davies et al., 2021, Lancet), a side effect not mentioned in this video.
  • A 2022 Obesity survey (Apovian et al.) found that some patients are dissatisfied with rapid facial hollowing from GLP-1-driven weight loss, a counterpoint to purely positive framing.
  • Early weight loss on semaglutide is typically inflated by water and glycogen loss. Fat loss rates tend to slow after the first few weeks as the body adapts.
  • This creator's results appear to be a statistical outlier. Using their timeline as a personal benchmark is likely to lead to frustration for most patients.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @ripdaddy.20 actually say?

The creator says they started semaglutide at 266 pounds and, about six weeks in, weighed 225 pounds, a 41-pound drop. They describe their face as having "dropped tremendously" and credit Ozempic directly for the facial change. They're sharing this as a personal win, not a medical tutorial, and that framing matters. This is a before-and-after post, not a dosing guide.

To be clear about what was claimed: significant facial fat loss, roughly 41 pounds of total body weight lost, and a timeline of approximately one and a half months. Those are the three things worth checking against the evidence. The emotional framing, "I know it's a lot of people who want to as well," signals this is meant as community encouragement, which is fine, but it also means 81,000+ viewers are absorbing these numbers as a baseline expectation.

Does the science back this up?

Partially, but the timeline is where this gets complicated. Semaglutide does produce real facial changes, but 41 pounds in six weeks is aggressive and not typical in clinical trial data.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed participants on semaglutide 2.4mg lost an average of 14.9% of body weight over 68 weeks. That's substantial, but it's spread over more than a year. Losing 15% of body weight in six weeks would be extraordinary and would raise questions about starting weight, dietary restriction, water weight, and adherence patterns.

Facial fat loss specifically, what the hashtag "ozempicface" refers to, is a documented side effect of rapid GLP-1-driven weight loss. A 2023 commentary in Facial Plastic Surgery and Aesthetic Medicine (Hartman et al.) acknowledged that rapid weight loss from GLP-1 agonists can reduce facial volume faster than skin elasticity can compensate. So the face change is real. The speed claimed here is the outlier.

What did they get wrong (or right)?

They got the core phenomenon right. Ozempic does change facial appearance during significant weight loss. That's not disputed.

What's harder to verify is the 41-pound figure in six weeks. That's not impossible, especially early in treatment when water weight and glycogen stores drop rapidly, but it's far above average. The STEP trials showed roughly 1 to 2 pounds per week as a typical rate after the initial water-weight phase. If this creator lost 41 pounds of actual fat mass in six weeks, that would require a caloric deficit of roughly 2,400 calories per day, which is physiologically extreme and potentially unsafe depending on protein intake and supervision.

They also don't mention side effects, which is worth noting. Nausea, vomiting, and gastrointestinal distress affect 30 to 44% of semaglutide users in clinical trials (Davies et al., 2021, Lancet). Not every creator has to disclose this, but viewers watching this as a decision-making resource deserve to know the 41-pound experience is likely not the median experience.

What should you actually know?

GLP-1 receptor agonists like semaglutide do cause facial volume loss during weight loss, and that effect is real and documented. But individual results vary significantly based on starting dose, titration schedule, diet, activity, and how much weight was water versus fat.

The phrase "my face has dropped tremendously" is accurate as a personal observation. But viewers should not use this video as a predictor of their own timeline. Clinical averages from the STEP program suggest more modest early losses, with larger cumulative effects over months to years.

There's also the question of loose skin and facial hollowing. Rapid weight loss, especially in the face, can produce a gaunt appearance that some patients find distressing. A 2022 survey published in Obesity (Apovian et al.) found that aesthetic concerns about facial changes were among the top reasons patients considered dose reduction or discontinuation. This creator looks good and is celebrating, which is valid. But the full picture of rapid facial fat loss includes cases where patients are not happy with the result.

If you're considering a GLP-1 medication, talk to a licensed provider about realistic timelines and what to expect in the first 30 to 90 days. A six-week transformation like this one is an outlier, not a benchmark.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

FONITA ❤️ · TikTok creator

81.3K views on this video

Month 2 of Ozempic Face Drop🥳I’m posting my accomplishments because I know it’s a lot of people Who Want to as well💜 #ozempicface

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about step 1 trial data (wilding et al., 2021, nejm) shows?

STEP 1 trial data (Wilding et al., 2021, NEJM) shows average semaglutide users lose about 14.9% of body weight over 68 weeks, not six weeks.

What does the video say about facial fat loss from glp-1 medications?

Facial fat loss from GLP-1 medications is real and documented, but it results from overall body weight reduction, not a targeted facial effect.

What does the video say about losing 41 pounds in six weeks would require an estimated?

Losing 41 pounds in six weeks would require an estimated deficit of roughly 2,400 calories per day, which raises questions about how much was water weight versus fat mass.

What does the video say about up to 44% of semaglutide users in clinical trials experience?

Up to 44% of semaglutide users in clinical trials experience nausea or vomiting (Davies et al., 2021, Lancet), a side effect not mentioned in this video.

What does the video say about a 2022 obesity survey (apovian et al.) found?

A 2022 Obesity survey (Apovian et al.) found that some patients are dissatisfied with rapid facial hollowing from GLP-1-driven weight loss, a counterpoint to purely positive framing.

What does the video say about early weight loss on semaglutide?

Early weight loss on semaglutide is typically inflated by water and glycogen loss. Fat loss rates tend to slow after the first few weeks as the body adapts.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by FONITA ❤️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.